3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Melanoma
1
Carcinoma, Merkel Cell
1
Carcinoma, Basal Cell
1
Interventions
pembrolizumab
9
Nivolumab
5
aldesleukin
2
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
Ipilimumab
2
Interleukin-2
2
Cyclophosphamide
2
Biopsy
2
sargramostim
1
relatlimab
1
regorafenib
1
prednylidene
1
lutetium Lu 177 dotatate
1
fludarabine phosphate
1
fludarabine
1
deltacortene
1
avelumab
1
aflibercept
1
X-Rays
1
Sirolimus
1
Sentinel Lymph Node Biopsy
1
Radiotherapy
1
Prednisone
1
Predictive Learning Models
1
Paclitaxel
1
Opdualag
1
NEO212
1
Lidocaine, Prilocaine Drug Combination
1
Laparoscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Carcinoma, Merkel Cell
×
Predictive Learning Models
×
Clear all
NCT06536257
2025-09-18
PIP-PREDICT
Melanoma Institute Australia
Recruiting
1,000 enrolled